Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management (CBL-0201WR Phase 2). The study will evaluate CBL-514 in...
Eastern International Ltd. Entered into Contract for its First Photovoltaic Power Generation Construction Project With a Total Contract Price of RMB 42.5 Million (approximately US$ 6.04 million)
HANGZHOU, China, Dec. 24, 2025 /PRNewswire/ -- Eastern International Ltd. ("Eastern International" or the "Company") (NASDAQ: ELOG), a provider of domestic and cross-border professional logistic services including project logistic and general...
Canadian Solar Appoints Colin Parkin as President and Dylan Marx as Chief Operating Officer
KITCHENER, ON, Dec. 24, 2025 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced the appointment of Colin Parkin as a member of its Board of Directors and his promotion to President of Canadian...
Bybit Releases Its 29th Proof-of-Reserves Report
DUBAI, UAE, Dec. 24, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, announced the publication of its 29th Proof-of-Reserves (PoR) snapshot, reflecting data accurate as of Dec. 17, 2025. The report,...
Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
CAMBRIDGE, Mass., Dec. 24, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the expansion of its integrated discovery and development...
NSF Retail Food Safety Audits Launch in Thailand with Nadimos Lebanese Restaurant as First Site to Achieve Compliance
Verified food retailers and restaurants demonstrate a strong commitment to hygiene, food safety and regulatory compliance BANGKOK, Dec. 24, 2025 /PRNewswire/ -- NSF, a leading global public health and safety organization, today announced that...
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Gastric Cancer.
SEONGNAM, South Korea, Dec. 24, 2025 /PRNewswire/ -- SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101...
CES 2026 Preview: Kosmera Prototype Debuts, Redefining the Intelligent Hypercar
LAS VEGAS, Dec. 24, 2025 /PRNewswire/ -- Kosmera, a brand dedicated to forging the future of intelligent mobility, announced today that its first-ever prototype—a new energy hypercar—will make its global debut at the 2026 Consumer Electronics Show...
Puainta Smashes Black Friday Records and Marks Successful Entry into UK Market
LOS ANGELES, Dec. 24, 2025 /PRNewswire/ -- Puainta, a rapidly growing innovator in pet healthcare and wellness, today announced significant milestones following the 2025 Black Friday sales event. The brand reported an unprecedented surge in global...
GreenTree Hospitality Group Ltd. Reports Third Quarter of 2025 Financial Results
Total revenues decreased by 1 5 . 0 % year over year to RMB303.6 million (US$4 2 . 6 million) [1] . Income from operations was RMB 70.1 million (US$9. 8 million) [1] compared to RMB 106.4 million for the third quarter of 202 4 . Net income was RMB...